Document Classification

Section Type: METHODS

Text: a) APR group (23 CABG and 20 AVR) received aprotinin, 2 x 10 (6) KIU (280 mg) after induction, followed by an infusion of 0. 5 x 106 KIU. h-1 (70 mg. h-1) until chest closure, with a supplement to the oxygenator prime of 2 x 10 (6) KIU ; b) TRA group (22 CABG and 19 AVR) received tranexamic acid, 15 mg. kg-1 between the injection of heparin (400 IU. kg-1) and the beginning of ECC, 15 mg. kg-1 after protamin injection (1. 3 mg/100 IU of heparin) ; c) CTR group (10 CABG and 10 AVR), the control group, was not treated with an antifibrinolytic agent.